CARMA FUND I invests in early-stage companies and projects in Life Science and Healthcare, leveraging exclusive academic access, cross-sector expertise, and a strong European syndication network. The fund focuses on supporting innovative projects to bring them to market, addressing challenges in patient benefit and medical advancements with flexible investment modalities and long-term support.
Preferred startup development maturity for initial funding deployment.
Early-stage Life Science and Healthcare technologies, including therapeutics, diagnostics, medical devices, and digital health solutions.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...